High molecular weight chitosan oligosaccharide exhibited antifungal activity by misleading cell wall organization via targeting PHR transglucosidases. (1st June 2022)

• Record Type: Journal Article
• Authors: Li, Ruilian; Zhu, Limeng; Liu, Dongdong; Wang, Wenjing; Zhang, Chen; Jiao, Siming; Wei, Jinhua; Ren, Lishi; Zhang, Yuchen; Gou, Xun; Yuan, Xianghua; Du, Yuguang; Wang, Zhuo A.
• Is Part Of: Carbohydrate polymers. Volume 285(2022)
• Publication Date: 2022-06-01
• Subjects: Candida albicans -- Cell wall -- Biofilm -- Chitosan oligosaccharide -- PHR transglucosidases; Polysaccharides -- Periodicals; Polysaccharides -- Periodicals; Polysaccharides -- Périodiques; Electronic journals; 547.78
• DOI: 10.1016/j.carbpol.2022.119253
• Languages: English
• ISSNs: 0144-8617

Abstract

Abstract: The fungal cell wall is an ideal target for the design of antifungal drugs. In this study we used an analog of cell wall polymer, a highly deacetylated high molecular-weight chitosan oligosaccharide (HCOS), to test its effect against pathogenic Candida strains. Results showed that HCOS was successfully incorporated into the dynamic cell wall organization process and exhibited an apparent antifungal activity against both plankton and mature fungal biofilm, by impairing the cell wall integrity. Unexpectedly, mechanistic studies suggested that HCOS exerts its activity by interfering with family members of PHR β-(1, 3)-glucanosyl transferases and affecting the connection and assembly of cell wall polysaccharides. Furthermore, HCOS showed great synergistic activity with different fungicides against Candida cells, especially those in biofilm. These findings indicated HCOS has a great potential as an antifungal drug or drug synergist and proposed a novel antifungal strategy with structure-specific oligosaccharides mimicking cell wall polysaccharide fragments. Graphical abstract: Unlabelled Image